BIOSYENT INC (RX.CA) Stock Cash Flow
Canada - TSX-V:RX - CA0906901081 - Common Stock
11.2 CAD
-0.01 (-0.09%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 8.26M | 7.27M | 6.46M | 5.46M | 6.28M | |||
| Depreciation Amortization | 777.00K | 590.00K | 455.30K | 451.00K | 457.10K | |||
| Income Taxes - Deferred | -125.80K | -129.20K | -134.00K | -8.80K | -68.30K | |||
| Change In Working Capital | 2.72M | 888.40K | -1.45M | -1.09M | -2.18M | |||
| Interest Paid | 54.30K | 59.20K | N/A | N/A | N/A | |||
| Taxes Paid | 2.05M | 2.36M | 2.41M | 1.76M | 2.32M | |||
| Other non cash items | 339.10K | 44.20K | -275.60K | 140.80K | 179.60K | |||
| OPERATING CASH FLOW | 11.97M | 8.66M | 5.05M | 4.95M | 4.67M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -69.50K | -42.30K | -59.50K | -46.80K | -84.70K | |||
| Other Investing Activity | -2.83M | 3.33M | 943.40K | -10.74M | -4.75M | |||
| INVESTING CASH FLOW | -2.90M | 3.29M | 883.90K | -10.79M | -4.84M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -188.20K | -183.30K | -242.50K | -239.00K | -237.20K | |||
| Stock Issued/Repurchased | -4.17M | -4.93M | -3.19M | -3.65M | -1.84M | |||
| Dividend Paid | -2.16M | -2.08M | -1.91M | -484.00K | N/A | |||
| Other Financing Activity | -399.60K | -639.30K | -443.50K | N/A | N/A | |||
| FINANCING CASH FLOW | -6.92M | -7.83M | -5.78M | -4.37M | -2.08M | |||
| Exchange Rate Effect | -2.20K | 5.90K | -34.30K | 42.10K | -18.60K | |||
| CHANGE IN CASH | 2.15M | 4.13M | 120.00K | -10.17M | -2.26M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 11.97M | 8.66M | 5.05M | 4.95M | 4.67M | |||
| Capital Expenditure | -69.50K | -42.30K | -59.50K | -46.80K | -84.70K | |||
| FREE CASH FLOW | 11.90M | 8.62M | 5.00M | 4.90M | 4.59M | |||
All data in CAD